- Home
- SABS vs KXIN Comparison
SABS vs KXIN Comparison
Compare SABS & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- KXIN
- Stock Information
- Founded
- SABS 2014
- KXIN 2015
- Country
- SABS United States
- KXIN China
- Employees
- SABS N/A
- KXIN N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- SABS Health Care
- KXIN Consumer Discretionary
- Exchange
- SABS Nasdaq
- KXIN Nasdaq
- Market Cap
- SABS 15.8M
- KXIN 13.0M
- IPO Year
- SABS N/A
- KXIN N/A
- Fundamental
- Price
- SABS $1.85
- KXIN $0.95
- Analyst Decision
- SABS Strong Buy
- KXIN
- Analyst Count
- SABS 6
- KXIN 0
- Target Price
- SABS $11.17
- KXIN N/A
- AVG Volume (30 Days)
- SABS 58.6K
- KXIN 194.1K
- Earning Date
- SABS 05-27-2025
- KXIN 01-01-0001
- Dividend Yield
- SABS N/A
- KXIN N/A
- EPS Growth
- SABS N/A
- KXIN N/A
- EPS
- SABS N/A
- KXIN N/A
- Revenue
- SABS $377,835.00
- KXIN N/A
- Revenue This Year
- SABS N/A
- KXIN N/A
- Revenue Next Year
- SABS $50.00
- KXIN N/A
- P/E Ratio
- SABS N/A
- KXIN N/A
- Revenue Growth
- SABS N/A
- KXIN N/A
- 52 Week Low
- SABS $1.00
- KXIN $0.64
- 52 Week High
- SABS $5.01
- KXIN $29.52
- Technical
- Relative Strength Index (RSI)
- SABS 58.32
- KXIN 49.30
- Support Level
- SABS $1.76
- KXIN $0.89
- Resistance Level
- SABS $2.15
- KXIN $1.11
- Average True Range (ATR)
- SABS 0.19
- KXIN 0.07
- MACD
- SABS 0.02
- KXIN 0.01
- Stochastic Oscillator
- SABS 51.61
- KXIN 39.31
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.